The New Frontier of R+D: Pharmacogenomics and Systems Biology
Organization:
The Women's Technology Cluster
Category:
Business
Geographical Area:
San Fran/Silicon Valley
Start
Date:
7/20/2006
End Date:
7/20/2006
Start Time:
7:30AM
End Time:
10:00AM
Event
Info:
Recent advancements in pharmacogenomics and systems biology are impacting research and development of therapeutics and may turn R&D into straight-forward engineering processes. Therapies are now targeted to patients' genetic profiles. Who are the key players in this space and how will they create this paradigm shift? How will these advances in technology change the way that we approach research and medicine?
Mark A. McCamish, M.D., Ph.D., Chief Medical Officer, Perlegen Sciences, Inc. Nancy Mize, Ph.D., Pharmacogenomics & Biomarker Lead Pacific BioDeveloment, LLC Mikhail Gishizky, Ph.D., Chief Scientific Officer, Entelos
DISCLAIMER: Our aim is to continuously provide our
progressive audience with an open and interactive medium to view
and share relevant,
beneficial and interesting "career, economic, lifestyle and
networking" listings, ads, content and resources.
While the above information may be accurate and viable, the role
of Minority Professional Network, Inc. (MPN) is
strictly as a communications medium, and we do not
accept any responsibility for
cancellation, changes, errors, omissions, inconveniences, or any other form
of liability for any content
displayed or disseminated via our web sites, or e-marketing or social media
promotional services.
If there are any
doubts, we
encourage you to conduct additional research or contact the listed host or responsible entity.
CLICK HERE to inform us about any ads, listings or content
which appear to be
inappropriate,
fraudulent or misleading, or inconsistent with our theme and focus.